Gainers
- ENDRA Life Sciences (NASDAQ:NDRA) stock increased by 71.6% to $0.15 during Wednesday's pre-market session. The company's market cap stands at $1.5 million.
- Concord Medical Services (NYSE:CCM) stock moved upwards by 29.04% to $2.71. The company's market cap stands at $117.6 million.
- Barinthus Biotherapeutics (NASDAQ:BRNS) shares increased by 21.69% to $2.3. The market value of their outstanding shares is at $89.7 million.
- Heart Test Laboratories (NASDAQ:HSCS) stock moved upwards by 12.87% to $5.81. The company's market cap stands at $3.8 million.
- I-MAB (NASDAQ:IMAB) shares increased by 12.23% to $2.11. The company's market cap stands at $170.6 million.
- Agenus (NASDAQ:AGEN) stock rose 11.54% to $19.52. The company's market cap stands at $409.9 million.
Losers
- SILO Pharma (NASDAQ:SILO) shares declined by 34.7% to $1.47 during Wednesday's pre-market session. The company's market cap stands at $4.1 million.
- Cue Health (NASDAQ:HLTH) stock decreased by 25.57% to $0.05. The company's market cap stands at $7.3 million.
- Fresh2 Group (NASDAQ:FRES) stock decreased by 20.52% to $0.35. The market value of their outstanding shares is at $8.6 million.
- ThermoGenesis Holdings (NASDAQ:THMO) stock fell 13.31% to $0.55. The market value of their outstanding shares is at $4.4 million.
- Compass Pathways (NASDAQ:CMPS) shares decreased by 13.3% to $6.65. The company's market cap stands at $454.7 million.
- Marker Therapeutics (NASDAQ:MRKR) stock fell 12.09% to $3.2. The market value of their outstanding shares is at $28.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BRNSBarinthus Biotherapeutics PLC
$0.73101.39%
CCMConcord Medical Services Holdings Ltd
$4.3522.9%
CMPSCompass Pathways PLC
$5.63-0.88%
HSCSHeartSciences Inc
$2.52-4.52%
MRKRMarker Therapeutics Inc
$1.40-1.41%
NDRAENDRA Life Sciences Inc
$5.30-3.60%
SILOSILO Pharma Inc
$0.4508-0.16%
THMOThermoGenesis Holdings Inc
$0.00010-100.0%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
